èšåºæ®µéã®ãã€ãªå»è¬åäŒæ¥ã§ãã Arcus Biosciences, Inc. ã¯ãç±³åœã§ããæ²»çè¬ã®éçºãšåååãè¡ã£ãŠããŸãã補åãã€ãã©ã€ã³ã«ã¯ããã§ãŒãº 1b/2 èšåºè©Šéšäžã®ãã¥ã¢ã« A2a/A2b ã¢ããã·ã³åå®¹äœæ®æè¬ Etrumadenant ããåå€çæ³ãšããŠãã§ãŒãº 1b èšåºè©Šéšäžã®æ PD-1 æäœ Zimberelimab ãªã©ããããŸããå瀟ã¯ãŸããæ TIGIT ã¢ãã¯ããŒãã«æäœ Domvanalimab ãéçºäžã§ããDomvanalimab ã¯ãZimberelimab ãšã®äœµçšã§è»¢ç§»æ§éå°çްèèºããã®ç¬¬äžéžææ²»çè¬ãšããŠãã§ãŒãº 2 éçºäžã§ãããŸããå°åå CD73 é»å®³å€ AB680 ã¯ã転移æ§èµèããã®ç¬¬äžéžææ²»çè¬ãšããŠãã§ãŒãº 1/1b 詊éšäžã§ããå瀟㯠Strata Oncology, Inc. ãš Zimberelimab ã®è©äŸ¡ã«é¢ããèšåºéçºååå¥çŽãç· çµããŠããŸããã¢ã¹ãã©ãŒãã«ç€Ÿãšã®ææºã§ã¯ãåé€äžèœãªã¹ããŒãžIIIã®éå°çްèèºããæ£è
ã察象ã«ãæ²»éšäžã®æTIGITæäœã§ãããã ãããªãããã€ã ãã£ã³ãžïŒãã¥ã«ãã«ããïŒãšçµã¿åãããŠç¬¬3çžç»é²èšåºè©Šéšã§è©äŸ¡ããŠããŸãããŸãã倧鵬è¬åå·¥æ¥æ ªåŒäŒç€Ÿãã¢ãã ãã»ã»ã©ãã¥ãŒãã£ã¯ã¹LLCãWuXi Biologicsãšãããæ²»ççšã®æCD39æäœãéçºããããã®ã©ã€ã»ã³ã¹å¥çŽãç· çµããŠããŸããå瀟ã¯2015幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ãã€ã¯ãŒãã«æ¬ç€Ÿã眮ããŠããŸãã